5929 N. May Ave. — Oklahoma City, Oklahoma

5929 N. May Ave. is a clinical research site located in Oklahoma City, Oklahoma, United States 73112.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

5929 N. May Ave. has participated in 1 clinical trials.

Therapeutic areas: Epilepsy With Simple or Complex Partial Onset Seizures.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 5929 N. May Ave.?

5929 N. May Ave. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 5929 N. May Ave. conducted?

5929 N. May Ave. has 1 clinical trials on record. Their work covers Epilepsy With Simple or Complex Partial Onset Seizures.

Is 5929 N. May Ave. accredited by Crixeo Health?

5929 N. May Ave. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 5929 N. May Ave.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.